Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 11:49 AM
NCT ID: NCT00324116
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00324116
Study Brief: Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Pegaptanib Sodium All subjects received a 0.3 mg/eye pegaptanib sodium intravitreous injection every 6 weeks for 54 weeks. None None 8 None 28 None View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Cardiac failure SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (v12.0) View
Cardiac failure acute SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (v12.0) View
Cataract operation SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (v12.0) View
Macular degeneration SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (v12.0) View
Peritonitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (v12.0) View
Pyelonephritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (v12.0) View
Angina unstable SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (v12.0) View
Retinal haemorrhage SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (v12.0) View
Suicide attempt SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (v12.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Conjunctival haemorrhage SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (v12.0) View
Eye pain SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (v12.0) View
Macular degeneration SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (v12.0) View
Myodesopsia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (v12.0) View
Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (v12.0) View